GOLDMAN SACHS GROUP INC - ELIEM THERAPEUTICS INC ownership

ELIEM THERAPEUTICS INC's ticker is and the CUSIP is 28658R106. A total of 36 filers reported holding ELIEM THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ELIEM THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$492,000
-64.5%
162,792
-1.4%
0.00%
Q1 2022$1,385,000
-19.3%
165,087
+0.6%
0.00%
Q4 2021$1,717,000
-42.5%
164,123
-1.1%
0.00%
-100.0%
Q3 2021$2,984,000165,9520.00%
Other shareholders
ELIEM THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
BML Capital Management, LLC 1,583,170$4,432,8763.99%
RA Capital Management 13,150,849$36,822,3770.70%
SILVERARC CAPITAL MANAGEMENT, LLC 494,089$1,383,4490.43%
Atom Investors LP 78,886$220,8810.08%
DRIEHAUS CAPITAL MANAGEMENT LLC 810,593$2,269,6600.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 55,223$154,6240.00%
Chicago Partners Investment Group LLC 16,570$45,7330.00%
TWO SIGMA SECURITIES, LLC 14,279$39,9810.00%
TUDOR INVESTMENT CORP ET AL 29,706$83,1770.00%
NORTHERN TRUST CORP 11,182$31,3100.00%
View complete list of ELIEM THERAPEUTICS INC shareholders